The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject^® (ferric carboxymaltose), for the management of iron deficiency in patients with HF.

Phase IV HEART-FID study results and ferric carboxymaltose...